Aigen Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.2M |
| 2 |
Kimberly-Clark
KMB
|
+$8.57M |
| 3 |
SBA Communications
SBAC
|
+$7.81M |
| 4 |
PG&E
PCG
|
+$5.73M |
| 5 |
Advance Auto Parts
AAP
|
+$5.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.6M |
| 2 |
Pfizer
PFE
|
+$14.6M |
| 3 |
Dominion Energy
D
|
+$13.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.9M |
| 5 |
Cadence Design Systems
CDNS
|
+$9.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.26% |
| 2 | Technology | 16.1% |
| 3 | Industrials | 11.55% |
| 4 | Financials | 11.01% |
| 5 | Healthcare | 10.26% |
Similar funds
Aigen Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.
- Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
- Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
- Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
- Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
- Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
- Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
- Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.
Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.